Impact felt the most in specialties with high screening rates, least in interventional radiology.
The “Safer at Home” order issued early in the COVID-19 pandemic was intended to help stem the spread of the virus, but it also led to the much-discussed, significant drop-off in imaging services.
According to an e-poster that will be presented during the 2021 ARRS Virtual Annual Meeting, this protective order prompted a reduction in radiology ordering, outpatient consultations, and emergency department visits. The results, presented by investigators from Olive View-UCLA Medical Center, point to a 40-percent decline in radiology orders during the that time period.
“There was a disproportionate impact in the outpatient setting, especially on screening and other non-essential imaging,” wrote Evan Raff, M.D., MHA, patient safety officer for the radiology department, “which mirrors the impact that the order has had on clinical services, as reflected in outpatient consult volumes, with larger declines in specialties with high screening rates, including in gastroenterology, optometry/ophthalmology, and gynecology.”
By reviewing radiology orders, indications, and appropriateness for the studies conducted at Los Angeles County’s Department of Health Services system, Raff pinpointed a 40-percent drop that followed the “Safer at Home” order. In addition, he also found a 67-percent drop in outpatient volumes, a 21-percent decline in emergency department volumes, and a 13-percent reduction in inpatient volumes.
From his analysis, dexa and breast imaging felt the greatest impact with volumes that plummeted by 88 percent and 80 percent, respectively. Body CT and interventional radiology fared better – 29 percent and 26 percent declines, respectively.
His evaluation even unearthed a 44-percent decline in emergency department visits that are typically viewed as urgent and essential.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.